Cargando…

The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway

BACKGROUND: Chemo-resistance is a leading cause of tumor relapse and treatment failure in patients with ovarian cancer. The identification of effective strategies to overcome drug resistance will have a significant clinical impact on the disease. METHODS: The protein and mRNA expression of GOLPH3L i...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Shanyang, Niu, Gang, Shang, Jianhong, Deng, Yalan, Wan, Zhiyong, Zhang, Cai, You, Zeshan, Shen, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628490/ https://www.ncbi.nlm.nih.gov/pubmed/28978336 http://dx.doi.org/10.1186/s13046-017-0607-0

Ejemplares similares

FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2023)

Independent duplications of the Golgi phosphoprotein 3 oncogene in birds
por: Opazo, Juan C., et al.
Publicado: (2021)

PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer
por: Shen, Hongwei, et al.
Publicado: (2021)

Golgi phosphoprotein 2 in physiology and in diseases
por: Kim, Ha-Jeong, et al.
Publicado: (2012)

NF-κB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-κB activation
por: Neidel, Sarah, et al.
Publicado: (2019)

The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3
por: Sechi, Stefano, et al.
Publicado: (2015)

Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling
por: He, Shanyang, et al.
Publicado: (2018)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Golgi Phosphoprotein 3 Regulates the Physical Association of Glycolipid Glycosyltransferases †
por: Ruggiero, Fernando M., et al.
Publicado: (2022)

Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas
por: Wang, Xu, et al.
Publicado: (2019)

Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients
por: Lu, Jianlei, et al.
Publicado: (2019)

Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility
por: Liu, Yiming, et al.
Publicado: (2016)

Human Golgi phosphoprotein 3 is an effector of RAB1A and RAB1B
por: Cavieres, Viviana A., et al.
Publicado: (2020)

Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers
por: Wang, Chun-Xiao, et al.
Publicado: (2021)

Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis
por: Wang, Tao, et al.
Publicado: (2021)

Transcriptional Regulation of PIK3CA Oncogene by NF-κB in Ovarian Cancer Microenvironment
por: Yang, Nuo, et al.
Publicado: (2008)

Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
por: Hua, Xing, et al.
Publicado: (2012)

Golgi phosphoprotein 3 induces autophagy and epithelial–mesenchymal transition to promote metastasis in colon cancer
por: Gong, Li-Yun, et al.
Publicado: (2022)

ZFP91: A Noncanonical NF-κB Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer
por: Paschke, Lukasz, et al.
Publicado: (2016)

Stress‐induced phosphoprotein 1 restrains spinal cord ischaemia‐reperfusion injury by modulating NF‐κB signalling
por: Jin, Hongdou, et al.
Publicado: (2021)

Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome
por: Zhu, Zhencheng, et al.
Publicado: (2021)

Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway
por: Liu, Hongying, et al.
Publicado: (2018)

Overexpression of glycosyltransferase 8 domain containing 2 confers ovarian cancer to CDDP resistance by activating FGFR/PI3K signalling axis
por: Huang, Shuting, et al.
Publicado: (2021)

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
por: Koussounadis, Antonis, et al.
Publicado: (2016)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
por: Yang, Danli, et al.
Publicado: (2021)

TRAF2 is an NF-κB activating oncogene in epithelial cancers
por: Shen, Rhine R., et al.
Publicado: (2013)

Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion
por: Byrne, Anne-Marie, et al.
Publicado: (2015)

Knockdown of Golgi phosphoprotein 73 blocks the trafficking of matrix metalloproteinase‐2 in hepatocellular carcinoma cells and inhibits cell invasion
por: Liu, Yiming, et al.
Publicado: (2019)

Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis
por: Shi, Wenhua, et al.
Publicado: (2019)

Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition
por: Wen, Yu, et al.
Publicado: (2019)

Golgi Phosphoprotein 3 Promotes Colon Cancer Cell Metastasis Through STAT3 and Integrin α3 Pathways
por: Huang, Anpei, et al.
Publicado: (2022)

NF-κB Signaling in Ovarian Cancer
por: Harrington, Brittney S., et al.
Publicado: (2019)

Overexpression of phosphoprotein enriched in astrocytes 15 reverses the damage induced by propofol in hippocampal neurons
por: Xian, Feng, et al.
Publicado: (2019)

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB
por: Zuo, Lielian, et al.
Publicado: (2015)

The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma
por: Lee, Dong Whan, et al.
Publicado: (2013)

Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses
por: Struzik, Justyna, et al.
Publicado: (2018)

Distinct Biochemical Pools of Golgi Phosphoprotein 3 in the Human Breast Cancer Cell Lines MCF7 and MDA-MB-231
por: Tenorio, María J., et al.
Publicado: (2016)

Golgi Phosphoprotein 3 Inhibits the Apoptosis of Human Glioma Cells in Part by Downregulating N-myc Downstream Regulated Gene 1
por: Li, Xin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tpr0p9lm5313brq6k3me688a6q